Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026837 (
muscle rigidity
)
1,077
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Experiments in rats showed that intrastriatal administration of kainic acid in a dose of 100 but not 20 ng per side resulted in the development of behavioral disorders reminding those of Parkinsonian syndrome: bradykinesia, increased
muscle rigidity
, ptosis. Intrastriatal administration of
galanin
in doses of 10 and 50 ng induced only a decrease of locomotor activity in the "open field". When co-administered with kainic acid (20 ng),
galanin
displayed a dose-dependent potentiation of behavioral Parkinsonian-like disturbances the severity of which increased depending on the dose used. It is concluded that
galanin
potentiates the kainic acid-induced development of the generator of pathologically enhanced excitation in the striatum underlying the mechanisms of Parkinsonian syndrome. Thus, the increased galaninergic striatal activity could participate in the mechanisms of the above-mentioned CNS disorders.
...
PMID:[The effect of galanin on the experimental parkinsonian syndrome in rats induced by the intrastriatal administration of kainic acid]. 750 70